An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile
Author
Abstract
Suggested Citation
Download full text from publisher
Other versions of this item:
- María José Abud & Bronwyn Hall & Christian Helmers, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-17, April.
- María José Abud Sittler & Bronwyn Hall & Christian Helmers, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," NBER Working Papers 20995, National Bureau of Economic Research, Inc.
References listed on IDEAS
- Amy Kapczynski & Chan Park & Bhaven Sampat, 2012. "Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents," PLOS ONE, Public Library of Science, vol. 7(12), pages 1-9, December.
- Sternitzke, Christian, 2013. "An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitors," Research Policy, Elsevier, vol. 42(2), pages 542-551.
- Panle Jia & Pinelopi K. Goldberg & Shubham Chaudhuri, 2006.
"Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India,"
American Economic Review, American Economic Association, vol. 96(5), pages 1477-1514, December.
- Shubham Chaudhuri & Pinelopi K. Goldberg & Panle Jia, 2003. "Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India," NBER Working Papers 10159, National Bureau of Economic Research, Inc.
- Shubham Chaudhuri, 2006. "Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India," Working Papers id:772, eSocialSciences.
- Maria Jose Abud & Carsten Fink & Bronwyn Hall & Christian Helmers, 2013. "The use of intellectual property in Chile," WIPO Economic Research Working Papers 11, World Intellectual Property Organization - Economics and Statistics Division.
- Pinelopi Koujianou Goldberg, 2010. "Alfred Marshall Lecture Intellectual Property Rights Protection in Developing Countries: The Case of Pharmaceuticals," Journal of the European Economic Association, MIT Press, vol. 8(2-3), pages 326-353, 04-05.
- Hemphill, C. Scott & Sampat, Bhaven N., 2012. "Evergreening, patent challenges, and effective market life in pharmaceuticals," Journal of Health Economics, Elsevier, vol. 31(2), pages 327-339.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Anckaert, Paul-Emmanuel, 2025.
"When the drugs (don’t) work: The role of science in product commercialization,"
Research Policy, Elsevier, vol. 54(5).
- Paul-Emmanuel Anckaert, 2025. "When the drugs (don’t) work: The role of science in product commercialization," Post-Print hal-05045289, HAL.
- Sampat, Bhaven N. & Shadlen, Kenneth C., 2017.
"Secondary pharmaceutical patenting: A global perspective,"
Research Policy, Elsevier, vol. 46(3), pages 693-707.
- Bhaven N. Sampat & Kenneth C. Shadlen, 2017. "Secondary Pharmaceutical Patenting: A Global Perspective," NBER Working Papers 23114, National Bureau of Economic Research, Inc.
- Minyoung Kim & Curba Morris Lampert & Raja Roy, 2020. "Regionalization of R&D activities: (Dis)economies of interdependence and inventive performance," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 51(7), pages 1054-1075, September.
- Luis Gil Abinader, 2020. "Pharmaceutical patent examination outcomes in the Dominican Republic," Journal of International Business Policy, Palgrave Macmillan, vol. 3(4), pages 385-407, December.
- Fabian Gaessler & Stefan Wagner, 2022.
"Patents, Data Exclusivity, and the Development of New Drugs,"
The Review of Economics and Statistics, MIT Press, vol. 104(3), pages 571-586, May.
- Gaessler, Fabian & Wagner, Stefan, 2019. "Patents, Data Exclusivity, and the Development of New Drugs," Rationality and Competition Discussion Paper Series 176, CRC TRR 190 Rationality and Competition.
- Pinto, Pablo E. & Vallone, Andres & Honores, Guillermo, 2019. "The structure of collaboration networks: Findings from three decades of co-invention patents in Chile," Journal of Informetrics, Elsevier, vol. 13(4).
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Chatterjee, Chirantan & Kubo, Kensuke & Pingali, Viswanath, 2015. "The consumer welfare implications of governmental policies and firm strategy in markets for medicines," Journal of Health Economics, Elsevier, vol. 44(C), pages 255-273.
- Wagner, Stefan & Sternitzke, Christian & Walter, Sascha, 2022.
"Mapping Markush,"
Research Policy, Elsevier, vol. 51(10).
- Stefan Wagner & Christian Sternitzke & Sascha Walter, 2022. "Mapping Markush," ESMT Research Working Papers ESMT-22-05, ESMT European School of Management and Technology.
- Eric W. Bond & Kamal Saggi, 2023.
"Compulsory licensing, price controls, and access to patented foreign products,"
World Scientific Book Chapters, in: Kamal Saggi (ed.), Technology Transfer, Foreign Direct Investment, and the Protection of Intellectual Property in the Global Economy, chapter 19, pages 437-448,
World Scientific Publishing Co. Pte. Ltd..
- Bond, Eric W. & Saggi, Kamal, 2014. "Compulsory licensing, price controls, and access to patented foreign products," Journal of Development Economics, Elsevier, vol. 109(C), pages 217-228.
- Eric Saggi & Saggi Saggi, 2012. "Compulsory licensing, price controls, and access to patented foreign products," Vanderbilt University Department of Economics Working Papers 12-00006, Vanderbilt University Department of Economics.
- Hazel V. J. Moir, 2016. "Exploring Evergreening: Insights from Two Medicines," Australian Economic Review, The University of Melbourne, Melbourne Institute of Applied Economic and Social Research, vol. 49(4), pages 413-431, December.
- Bennato, Anna Rita & Valletti, Tommaso, 2014.
"Pharmaceutical innovation and parallel trade,"
International Journal of Industrial Organization, Elsevier, vol. 33(C), pages 83-92.
- Anna Rita Bennato & Tommaso Valletti, 2012. "Pharmaceutical Innovation and Parallel Trade," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2012-09, Centre for Competition Policy, University of East Anglia, Norwich, UK..
- Wang, Lucy Xiaolu, 2022. "Global drug diffusion and innovation with the medicines patent pool," Journal of Health Economics, Elsevier, vol. 85(C).
- Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2016.
"The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India,"
American Economic Review, American Economic Association, vol. 106(1), pages 99-135, January.
- Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2014. "The Market Impacts Of Pharmaceutical Product Patents In Developing Countries: Evidence From India," Discussion Papers 14-005, Stanford Institute for Economic Policy Research.
- Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2014. "The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India," NBER Working Papers 20548, National Bureau of Economic Research, Inc.
- Margaret K. Kyle, 2020.
"The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals,"
Innovation Policy and the Economy, University of Chicago Press, vol. 20(1), pages 95-123.
- Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
- Margaret Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," Post-Print hal-02452622, HAL.
- Margaret Kyle, 2020. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," Post-Print hal-03109956, HAL.
- Auriol, Emmanuelle & Biancini, Sara & Paillacar, Rodrigo, 2015. "Intellectual Property Rights Protection and Trade," CEPR Discussion Papers 10602, C.E.P.R. Discussion Papers.
- Durvasula, Maya & Hemphill, C. Scott & Ouellette, Lisa Larrimore & Sampat, Bhaven & Williams, Heidi L., 2023.
"The NBER Orange Book Dataset: A user’s guide,"
Research Policy, Elsevier, vol. 52(7).
- Maya Durvasula & C. Scott Hemphill & Lisa Larrimore Ouellette & Bhaven N. Sampat & Heidi L. Williams, 2022. "The NBER Orange Book Dataset: A User’s Guide," NBER Working Papers 30628, National Bureau of Economic Research, Inc.
- Wagner, Stefan & Wakeman, Simon, 2016.
"What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry,"
Research Policy, Elsevier, vol. 45(5), pages 1091-1102.
- Stefan Wagner & Simon Wakeman, 2014. "What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry," ESMT Research Working Papers ESMT-14-01 (R1), ESMT European School of Management and Technology, revised 09 Mar 2015.
- Neil Gandal & Michal Shur-Ofry & Michael Crystal & Royee Shilony, 2021. "Out of sight: patents that have never been cited," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(4), pages 2903-2929, April.
- Kamal Saggi, 2016. "Trade, Intellectual Property Rights, and the World Trade Organization," Vanderbilt University Department of Economics Working Papers 16-00014, Vanderbilt University Department of Economics.
- Kamal Saggi, 2013.
"Market Power in the Global Economy: The Exhaustion and Protection of Intellectual Property,"
Economic Journal, Royal Economic Society, vol. 123(567), pages 131-161, March.
- Kamal Saggi, 2011. "Market power in the global economy: the exhaustion and protection of intellectual property," Vanderbilt University Department of Economics Working Papers 1114, Vanderbilt University Department of Economics.
- Kamal Saggi, 2012. "Market power in the global economy: the exhaustion and protection of intellectual property," Vanderbilt University Department of Economics Working Papers 12-00005, Vanderbilt University Department of Economics.
- Farasat A.S. Bokhari & Weijie Yan, 2020.
"Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market,"
Working Paper series, University of East Anglia, Centre for Competition Policy (CCP)
2020-04, Centre for Competition Policy, University of East Anglia, Norwich, UK..
- Bokhari, Farasat A. S. & Yan, Weijie, 2020. "Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market," Papers WP678, Economic and Social Research Institute (ESRI).
- Kevin Gallagher, 2011. "Trading Away Stability and Growth: United States Trade Agreements in Latin America," Working Papers wp266, Political Economy Research Institute, University of Massachusetts at Amherst.
- Mayank Aggarwal & Anindya S. Chakrabarti & Chirantan Chatterjee, 2023. "Movies, stigma and choice: Evidence from the pharmaceutical industry," Health Economics, John Wiley & Sons, Ltd., vol. 32(5), pages 1019-1039, May.
- Amy Kapczynski & Chan Park & Bhaven Sampat, 2012. "Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents," PLOS ONE, Public Library of Science, vol. 7(12), pages 1-9, December.
- Gnekpe, Christian & Jimenez, Alfredo, 2023. "Smoke signal: When firms' patent strategy and local patent protection system affect equity stakes in cross-border acquisitions," Journal of International Management, Elsevier, vol. 29(6).
- Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022.
"Generic competition and the incentives for early-stage pharmaceutical innovation,"
Research Policy, Elsevier, vol. 51(10).
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
More about this item
Keywords
; ; ; ; ; ; ; ; ; ;JEL classification:
- K12 - Law and Economics - - Basic Areas of Law - - - Contract Law
- L5 - Industrial Organization - - Regulation and Industrial Policy
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
- O34 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Intellectual Property and Intellectual Capital
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:cdl:econwp:qt9tv8s2rw. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Lisa Schiff (email available below). General contact details of provider: https://edirc.repec.org/data/ibbrkus.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.